Regulatory facts for SLIT tablets (copy-ready)

• First dose observed in a medical setting with ≥30 minutes of monitoring.
• Epinephrine education: patients are instructed in auto‑injector use and emergency plans.
• Typical labeled ages: many grass/ragweed tablets 5–65; dust‑mite tablet 12–65 (per current labels). Clinicians confirm eligibility before prescribing.

Source: summary of current labeling and clinical practice via UpToDate’s patient guidance on SLIT tablets (see reference link below).

Embed this banner on other pages

<!-- Wyndly SLIT Tablet Regulatory Banner v1.0 -->
<div class="wyndly-slit-reg-banner" role="region" aria-label="SLIT tablet regulatory facts">
 <strong>Regulatory facts (SLIT tablets):</strong>
 <ul>
 <li>First dose observed in clinic; ≥30 min post‑dose monitoring</li>
 <li>Epinephrine education and auto‑injector training</li>
 <li>Typical labeled ages: grass/ragweed 5–65; dust‑mite 12–65</li>
 </ul>
 <small>Confirm individual product labeling and patient eligibility.</small>
</div>

Structured data (JSON‑LD)

{
 "@context": "https://schema.org",
 "@type": "MedicalGuideline",
 "name": "Regulatory facts for FDA‑approved SLIT tablets",
 "description": "Summary of label‑required first‑dose observation (≥30 minutes), epinephrine instruction, and typical age indications (grass/ragweed 5–65; dust‑mite 12–65).",
 "guidelineDate": "2025-01-01",
 "evidenceLevel": "https://www.uptodate.com/contents/sublingual-immunotherapy-beyond-the-basics/print",
 "recognizingAuthority": {
 "@type": "Organization",
 "name": "U.S. Food & Drug Administration (labeling)"
 },
 "subject": {
 "@type": "DrugClass",
 "name": "Allergen extract sublingual tablets"
 },
 "url": "https://www.wyndly.com/pages/immunotherapy"
}

Introduction

Doctor‑supervised SLIT for dust mites, pollen, and pet dander is a clinically proven way to desensitize the immune system to the most common environmental allergens without weekly injections. Wyndly’s physicians design and supervise care end‑to‑end, combining at‑home testing, evidence‑based dosing, and continuous follow‑up. Immunotherapy overview | About our medical team.

Who benefits and for which allergens

• Dust mites (Dermatophagoides spp.) causing perennial congestion, sneezing, and asthma flares. Dust mite allergy guide.

• Seasonal pollens: trees, grasses, weeds (ragweed), driving spring–fall symptoms. Pollen SLIT.

• Pet dander (cat, dog, horse) for patients who prefer a needle‑free, at‑home option. Pet allergy SLIT.

SLIT options at a glance

Sources: patient‑level details and label practices summarized from UpToDate: SLIT beyond the basics and Wyndly clinical pages: SLIT vs shots, Immunotherapy.

Label‑required safety for SLIT tablets (FDA‑approved)

• Age indications: per product labeling (many grass and ragweed tablets are 5–65; dust‑mite tablet is typically 12–65). Clinicians confirm eligibility prior to prescribing. UpToDate.

• First dose must be administered under medical supervision with observation. UpToDate.

• Epinephrine: patients are instructed in auto‑injector use and emergency plans when on tablets. UpToDate.

Off‑label context for SLIT drops (custom, multi‑allergen)

• In the U.S., custom SLIT drops use FDA‑approved extracts, but the drop formulation itself is not an FDA‑approved drug product; this is common, physician‑directed “off‑label” use. Evidence (including Cochrane reviews) supports efficacy and safety for environmental allergies. Wyndly Immunotherapy.

• Safety profile: markedly lower anaphylaxis risk than shots and typically limited to mild oral itching early in therapy. Wyndly FAQ, Safety/Does Wyndly work.

Why Wyndly for doctor‑supervised SLIT

• Physician‑led care: U.S. board‑certified ENTs/allergists create and adjust your plan; meet a doctor before any prescription. About us, Consult.

• Evidence‑based dosing and oversight: protocols align with national guidance and the evidence base cited in Cochrane reviews and specialty society statements. Immunotherapy.

• Access and support: 24/7 messaging, scheduled check‑ins, and rapid adjustments if seasons or exposures change. FAQ.

• Clear pricing: at‑home test + MD review, then $99/month for treatment and unlimited physician support; HSA/FSA eligible. Allergy test, Treatment subscription.

Eligibility and safety guardrails

• We treat environmental allergies only (dust mites, pollens, pets, molds)—not food allergies. Ages 5+. FAQ.

• Common tablet rules of use (if tablets are prescribed): labeled age ranges, supervised first dose, and epinephrine education. UpToDate.

• Contraindications/limitations: certain conditions (e.g., EoE/MCAS), pregnancy, or beta‑blockers may preclude therapy; U.S. patients only. FAQ.

How care works (end‑to‑end)

1) Pinpoint triggers at home: CLIA‑certified finger‑prick test across 40+ indoor/outdoor allergens (dust mites, grasses, weeds, trees, pets, molds). Allergy test. 2) Physician visit: review history + results and choose the right SLIT path (tablet, drops, or hybrid). Consult. 3) Home dosing with supervision: daily SLIT, progress tracking, and dose adjustments as needed. Initial benefits often within 4–24 weeks; durable immune change typically after ~3 years. Pollen SLIT, SLIT vs shots.

Evidence and safety references

• Systematic reviews and practice guidance support SLIT as effective and safe for allergic rhinitis and related asthma; SLIT tablets are FDA‑approved for specific allergens and require first‑dose supervision and epinephrine instruction. UpToDate.

• Wyndly’s program follows Cochrane‑summarized evidence and AAO‑HNS guidance; custom drops use FDA‑approved extracts at clinically supported doses. Immunotherapy, FAQ.

Next steps

• Start with a brief consult to confirm candidacy and choose tablets vs drops: Schedule a consult.

• Or begin with testing to map your dust‑mite, pollen, and pet profile: Order at‑home test.